New Advances in Neuropharmacology

Dear Colleagues,

This Special Issue aims to showcase cutting-edge research in neuropharmacology, focusing on novel therapeutic strategies, molecular mechanisms, and translational innovations for neurological and psychiatric disorders. With rapid advancements in understanding neural circuitry, neuroinflammation, and synaptic plasticity, this field holds immense potential to address unmet clinical needs in conditions such as Parkinson's disease and Alzheimer's disease, psychological disorders, and many others.

We invite original research articles, reviews, and perspectives that explore emerging drug targets, innovative drug delivery systems, biomarker discovery, and the application of AI/ML in drug design. Contributions addressing pharmacogenomics, neuroprotection, and the repurposing of existing therapeutics are particularly encouraged. Submissions should emphasize mechanistic insights, preclinical-to-clinical translation, and implications for precision medicine.

This issue seeks to bridge interdisciplinary gaps, fostering collaboration among neuroscientists, pharmacologists, and clinicians. By highlighting transformative discoveries, we aim to accelerate the development of safer, more effective neurotherapeutics.

Authors are welcome to submit manuscripts aligned with these themes. All submissions will undergo rigorous peer review to ensure scientific rigor and relevance. Join us in advancing the field of neuropharmacology!

Dr. Yu-Cheng Ho
Dr. Ming Tatt Lee
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.